130 related articles for article (PubMed ID: 6128867)
21. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
[TBL] [Abstract][Full Text] [Related]
22. Acute haemodynamic effects of oral prenalterol in severe heart failure.
Petch MC; Wisbey C; Ormerod O; Scott C; Goodfellow RM
Br Heart J; 1984 Jul; 52(1):49-52. PubMed ID: 6146324
[TBL] [Abstract][Full Text] [Related]
23. Acute effects of beta 1 agonism with prenalterol on catecholamine circulating levels in patients with congestive heart failure.
Corea L; Bentivoglio M; Verdecchia P; Provvidenza M
G Ital Cardiol; 1983 Nov; 13(11):330-4. PubMed ID: 6141975
[TBL] [Abstract][Full Text] [Related]
24. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
[TBL] [Abstract][Full Text] [Related]
25. [Circulatory effects of prenalterol (a selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy].
Moruzzi P; Cipolla CM; Bartorelli A; Reggiani P; Ging LQ; Guazzi M
Cardiologia; 1982; 27(1):99-101. PubMed ID: 6152733
[No Abstract] [Full Text] [Related]
26. A dose response study with oral prenalterol in patients with chronic congestive cardiac failure.
Hendry WG; Comerford MB; Besterman EM
Clin Cardiol; 1984 Jan; 7(1):23-8. PubMed ID: 6705284
[TBL] [Abstract][Full Text] [Related]
27. [The use of beta-1-adrenergic agonists in the treatment of cardiac insufficiency].
Coulombe D
Ann Cardiol Angeiol (Paris); 1984; 33(4):207-10. PubMed ID: 6147113
[TBL] [Abstract][Full Text] [Related]
28. Lack of effect of prenalterol on dialysis-associated hypotension.
Ladefoged J
Eur J Clin Pharmacol; 1984; 26(3):399-400. PubMed ID: 6145594
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
Klein W; Brandt D; Maurer E
Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
[TBL] [Abstract][Full Text] [Related]
30. [Circulatory effects of prenalterol (selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy].
Moruzzi P; Cipolla CM; Bartorelli A; Reggiani P; Lu Quo Ging ; Guazzi M
Cardiologia; 1982; 27(1):99-101. PubMed ID: 6892381
[No Abstract] [Full Text] [Related]
31. Pharmacodynamic effects of prenalterol in healthy subjects.
Johnsson G
Acta Med Scand Suppl; 1982; 659():109-22. PubMed ID: 6127882
[TBL] [Abstract][Full Text] [Related]
32. [Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in swine with open thorax].
Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
Cardiologia; 1982; 27(1):33-43. PubMed ID: 6892371
[No Abstract] [Full Text] [Related]
33. Dose-dependent haemodynamic response to prenalterol in patients with congestive heart failure.
Leinberger H; Mäurer W; Haueisen H; Schuler G; Kübler W
Acta Med Scand Suppl; 1982; 659():299-306. PubMed ID: 6127896
[TBL] [Abstract][Full Text] [Related]
34. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure.
Lambertz H; Meyer J; Erbel R
Circulation; 1984 Feb; 69(2):298-305. PubMed ID: 6140091
[TBL] [Abstract][Full Text] [Related]
35. [New drugs with positive inotropic action].
Bijak A; Czołpiński T
Kardiol Pol; 1982; 25(4):357-65. PubMed ID: 6128439
[No Abstract] [Full Text] [Related]
36. Intravenous prenalterol in acute and chronic heart failure.
Kirlin PC; Pitt B; Lucchesi BR
Acta Med Scand Suppl; 1982; 659():263-86. PubMed ID: 6127894
[No Abstract] [Full Text] [Related]
37. Hemodynamic effects of atrial pacing and prenalterol infusion in patients taking beta-adrenergic blocking drugs.
Shiu MF; Ireland MA; Littler WA
Circulation; 1981 Dec; 64(6):1135-41. PubMed ID: 6117380
[TBL] [Abstract][Full Text] [Related]
38. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
Wirtzfeld A; Klein G; Bibra HV; Sauer E
Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
[TBL] [Abstract][Full Text] [Related]
39. Prenalterol in cardiogenic shock following acute myocardial infarction.
Coma-Canella I; Lopez-Sendon J; Jadraque LM
Am Heart J; 1984 Jun; 107(6):1195-201. PubMed ID: 6144265
[TBL] [Abstract][Full Text] [Related]
40. Haemodynamic effects of prenalterol in patients with coronary heart disease.
Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
